Obesity: this drug would revolutionize the health of patients

Researchers have made a discovery that may give hope to people who are obese. A drug intended for diabetics would lose between 10% and 20% of the body weight.

Semaglutide, a diabetes medicine to treat obesity

Obesity is an adipose tissue disease resulting from the entanglement of several factors – dietary, epigenetic genetics and environmental – involved in the development and progression of this chronic disease. It causes many complications: type 2 diabetes, cardiovascular, hepatic, renal, respiratory, articular, dermatological diseases, etc. A person is considered to be obese when their body mass index (BMI) is 30 or more.

Today, obesity concerns 17% of adults in France and 13% worldwide. For these people, The hope of a new treatment is allowed thanks to a drug intended to treat diabetes, semaglutide. This discovery is a major breakthrough that could, according to a study published in the New England Journal of Medicine , ” revolutionize »Patient health.

Lose weight with diabetes medication

To measure the effects of semaglutide, a drug that increases insulin production and reduces appetite, researchers conducted a study of 1,961 adults in 16 different countries. The participants were divided into three groups: two-thirds received semaglutide with advice on diet and exercise, and one-third received a placebo with the same advice.

Result: participants who received semaglutide lost an average of 15.3 kg, or between 10% and 20% of their body weight. Those who took the placebo lost only 2.4% of their weight. The other side of the coin is that this drug causes disorders (diarrhea, constipation, nausea, vomiting, etc.). Despite these drawbacks, 80% managed to complete the protocol, which lasted 18 months.

Design by NewsLax